U.S./Canada Price Gap Closing Thanks To Generics, Express Scripts Says
Executive Summary
The difference between U.S. and Canadian prescription drug prices is narrowing in the top therapeutic categories, Express Scripts CEO Barrett Toan told the Medicare Prescription Drug Congress Feb. 26 in Washington, D.C
You may also be interested in...
Express Scripts Sees Discounts From All Rx Firms For Medicare Card
Express Scripts expects all drug manufacturers to offer "meaningful discounts" for Medicare-endorsed drug card plans, CEO Barrett Toan told the Medicare Prescription Drug Congress Feb. 26
Generics, Not Reimportation, Are Solution To High Drug Costs – McClellan
States should encourage more generic drug use - not reimportation - as a way to lower pharmacy costs, FDA Commissioner McClellan said
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011